Consider This from NPR How A Bankruptcy Deal Could Offer Clean Slate For Opioid Billionaires
Aug 30, 2021
Brian Mann, NPR's addiction correspondent with years of experience covering Purdue Pharma, delves into the complex saga surrounding the Sackler family and their role in the opioid crisis. He discusses how a federal bankruptcy ruling may allow the Sacklers to retain their fortunes while victims seek justice. Listeners learn about the aggressive marketing of OxyContin, the family’s philanthropic image amidst scandal, and the implications of legal immunity that could hinder accountability for their actions.
AI Snips
Chapters
Transcript
Episode notes
Keola's Story
- Keola Kekeweva shared his experience with opioid addiction after receiving a letter from a federal judge.
- His story, along with others, is part of Purdue Pharma's bankruptcy trial.
Joanne's Advocacy
- Joanne Peterson became an opioid addiction activist after her niece and son became addicted.
- She believes Purdue Pharma and the Sackler family should be held accountable.
OxyContin's Introduction
- Purdue Pharma, once a small drug firm, introduced OxyContin, marketed as a less addictive opioid.
- This led to a surge in opioid prescriptions and subsequent addiction, despite claims of safety.